Psychedelic drug use linked to lower risk of psychological distress; Team tests a nanobody against norovirus;

> Building on a body of research that suggests certain party drugs can be used to effectively treat depression and other conditions, a new study by Johns Hopkins and the University of Alabama finds that a history of psychedelic drug use is linked to a lower risk of psychological distress, including a lower risk of suicidal thoughts. Release

> A team under Dr. Grant Hansman, a virologist who leads the CHS Research Group on Noroviruses at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University, has discovered that a "nanobody" called Nano-85 was able to bind to intact norovirus-like particles in culture. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.